Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Kezar Life Sciences Inc. logo

Kezar Life Sciences Inc.

Sector: Healthcare   

Industry: Biotechnology

0.84
 
USD
  
0.00
  
(0.06%)
Optionable: Yes  Market Cap: 63 M  90-day average vol: 566,136

Previous close: 0.8376  Open: 0.8544  Bid: 0.845  Ask: 0.8594
52 week range    
0.67   
   7.61
Peers   
OTIC / 
OTLC / 
OVAT-CA / 
Last updated: Monday 4th December 2023
40
MarketXLS Rank
60
Value
38
Technical
23
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

ORTH-CA

OTIC

0 B-2.52.03

OTLC

0 B-1.90.17

OVAT-CA

Financials

KZR Income Statement

Annual
Invalid dateDec-18Dec-19Dec-20Dec-21Dec-22
Basic EPS from continuing operations-1.84-0.95-1.04
Basic EPS total-1.84-0.95-1.04-1.01
Basic weighted shares outstanding10 M19 M44 M53 M67 M
Depreciation-700000.0900000.0900000.0900000.0-1000000.0
DepreciationAndAmortization-700000.0900000.0900000.0900000.0-1000000.0
Diluted EPS total-2.26-1.84-0.95-1.04-1.01
Diluted normalized net income/share-2.26
Diluted weighted shares outstanding10 M19 M44 M53 M67 M
GeneralAndAdministrativeExpense7 M10 M12 M16 M20 M
Income before tax-23 M-35 M-42 M-55 M-68 M
Interest income2 M2 M1 M188000.04 M
InterestExpenseNonOperating159000.01 M
Net income from total operations-23 M-35 M-42 M-55 M-68 M
NetIncomeCommonStockholders-23 M-35 M-42 M-55 M-68 M
NetIncomeContinuousOperations-23 M-35 M-42 M-55 M-68 M
NetNonOperatingInterestIncomeExpense2 M2 M1 M29000.03 M
Normalized income-43 M
Operating income-25 M-37 M-43 M-55 M-71 M
Operating income before depreciation (EBITDA)-23 M-35 M-40 M-51 M-67 M
OperatingExpense25 M37 M43 M55 M-71 M
OtherGandA7 M10 M12 M16 M20 M
OtherOperatingExpenses-25 M37 M-487000.0-775000.0-71 M
RentAndLandingFees-1000000.01 M1 M1 M20 M
Research & development expense18 M27 M31 M39 M51 M
ResearchExpense18 M27 M31 M39 M51 M
SalariesAndWages-2 M-14 M
Selling Gen & administrative expense7 M10 M12 M16 M20 M
Total Income available for interest expense (EBIT)-23 M-35 M-42 M-54 M-67 M
Total common shares outstanding19 M38 M48 M57 M71 M
Total net income-23 M-35 M-42 M-55 M-68 M
Total ordinary shares73 M73 M73 M73 M73 M
TotalExpenses25 M37 M43 M55 M-71 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder/CEO of MarketXLS. With over six years of experience, I've helped 2500+ customers implement personalized investment research strategies and monitoring systems in Excel.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.
Get started today